WuXi AppTec Reports First Half 2024 Financial Results WuXi AppTec, a global leader in R&D and manufacturing services for the pharmaceutical and life sciences sectors, has announced its financial results for the first half of 2024, ending June 30. Key…
AbbVie Announces European Approval of SKYRIZI® for Ulcerative Colitis AbbVie has received European Commission approval for SKYRIZI® (risankizumab) to treat adults with moderately to severely active ulcerative colitis (UC) who have not responded to or were intolerant of conventional or…
Autobahn Therapeutics, a biotech firm focused on innovative treatments for neuropsychiatric and neuroimmunologic disorders, has closed an oversubscribed $100 million Series C financing round. The funding was led by Newpath Partners and included new investors Canaan Partners, Monograph Capital, and…
Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) have announced a five-year extension of the RADIAN® partnership to address the growing HIV crisis in Eastern Europe and Central Asia (EECA). This partnership aims to support vulnerable…
AIDS Healthcare Foundation (AHF) will hold an in-person and virtual press conference at the AHF booth (#111) during the 2024 International AIDS Conference (AIDS 2024) on Tuesday, July 23, at 13:15 CEST (7:15 a.m. US EDT) in Munich, Germany, at…
Rusan Pharma, an India-based pharmaceutical company specializing in addiction treatment and pain management, recently announced that the United States Food and Drug Administration (USFDA) has granted Good Manufacturing Practice (GMP) approval for its Active Pharmaceutical Ingredient (API) facility in Ankleshwar,…
The WHO is actively participating in the 25th International AIDS Conference (AIDS 2024) in Munich, Germany, and online from July 20 to 26. During a series of pre-conference sessions and WHO-led satellite events, the Organization will present its latest epidemiological…
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino) announced today that its Korean subsidiary, Ono Pharma Korea Co., Ltd. (OPKR), received additional approval from South Korea’s Ministry of Food and Drug Safety (MFDS) on July 17. The approval…
Labcorp, a leading global life sciences company, has been recognized as a top employer for disability inclusion by achieving a perfect score of 100 on the 2024 Disability Equality Index®. The Disability Equality Index, established by Disability and the American…
BeiGene, a global oncology company, has announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Rosenberg will succeed Julia Wang, who is leaving to pursue other opportunities but will remain with the company through August to…
Global pharmaceutical leader Lupin Limited (Lupin) has announced the approval of its Abbreviated New Drug Application by the United States Food and Drug Administration (U.S. FDA) for Topiramate Extended-Release Capsules. This approval covers dosages of 25 mg, 50 mg, 100…
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has announced a definitive agreement to acquire APEIRON Biologics AG for $100 million in cash. APEIRON holds royalty rights to QARZIBA® (dinutuximab beta), a treatment for high-risk neuroblastoma. In addition to the initial payment, Ligand…